Evaluating Readministration of Adeno-Associated Virus for Gene Therapy

被引：2

作者：

Arjomandnejad, Motahareh ^{[1
]}

Keeler, Allison M. ^{[1
,2
,3
]}

机构：

[1] Univ Massachusetts, Chan Med Sch, Horae Gene Therapy Ctr, Worcester, MA 01655 USA

[2] Univ Massachusetts, Chan Med Sch, Dept Pediat, Worcester, MA USA

[3] Univ Massachusetts, Chan Med Sch, NeuroNexus Inst, Worcester, MA USA

来源：

HUMAN GENE THERAPY | 2022年 / 33卷 / 5-6期

关键词：

TRANSIENT IMMUNOSUPPRESSION; IMMUNE-RESPONSES; VECTORS; EXPRESSION; CTLA4-IG; TYPE-1;

D O I：

10.1089/hum.2022.29204.mar

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：218 / 220

页数：3

共 31 条

[1] Capsid-specific removal of circulating antibodies to adeno-associated virus vectors [J].

Bertin, Berangere ;

Veron, Philippe ;

Leborgne, Christian ;

Deschamps, Jack-Yves ;

Moullec, Sophie ;

Fromes, Yves ;

Collaud, Fanny ;

Boutin, Sylvie ;

Latournerie, Virginie ;

van Wittenberghe, Laetitia ;

Delache, Benoit ;

Le Grand, Roger ;

Dereuddre-Bosquet, Nathalie ;

Benveniste, Olivier ;

Moullier, Philippe ;

Masurier, Carole ;

Merten, Otto ;

Mingozzi, Federico .

SCIENTIFIC REPORTS, 2020, 10 (01)

[2] A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis [J].

Boumpas, DT ;

Furie, R ;

Manzi, S ;

Illei, GG ;

Wallace, DJ ;

Balow, JE ;

Vaishnaw, A .

ARTHRITIS AND RHEUMATISM, 2003, 48 (03) :719-727

[3] Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors [J].

Boutin, Sylvie ;

Monteilhet, Virginie ;

Veron, Philippe ;

Leborgne, Christian ;

Benveniste, Olivier ;

Montus, Marie Francoise ;

Masurier, Carole .

HUMAN GENE THERAPY, 2010, 21 (06) :704-712

[4] Costimulation blockade by combining CTLA4Ig with anti-CD40L mAb markedly inhibits the inflammatory response of experimental autoimmune myocarditis [J].

Chen, Qing-Quan ;

Chen, Min ;

Zhang, Li-Hua ;

Zeng, Yu ;

Liu, Qi-Cai ;

Yang, Xiu-Lin ;

Lin, Xu-Chen .

EUROPEAN JOURNAL OF INFLAMMATION, 2017, 15 (01) :28-34

[5]

Corti M., MOL THER-METH CLIN D

[6] Rescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme [J].

Elmore, Zachary C. ;

Oh, Daniel K. ;

Simon, Katherine E. ;

Fanous, Marco M. ;

Asokan, Aravind .

JCI INSIGHT, 2020, 5 (19)

[7] Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis [J].

Fadul, Camilo E. ;

Mao-Draayer, Yang ;

Ryan, Kathleen A. ;

Noelle, Randolph J. ;

Wishart, Heather A. ;

Channon, Jacqueline Y. ;

Kasper, Isaac R. ;

Oliver, Brant ;

Mielcarz, Daniel W. ;

Kasper, Lloyd H. .

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (06)

[8] Revisiting the "New'' Inflammatory Toxicities of Adeno-Associated Virus Vectors [J].

Flotte, Terence R. .

HUMAN GENE THERAPY, 2020, 31 (7-8) :398-399

[9] Blockade of the costimulatory CD28-B7 family signal axis enables repeated application of AAV8 gene vectors [J].

Frentsch, Marco ;

Japp, Alberto Sada ;

Dingeldey, Manuela ;

Matzmohr, Nadine ;

Thiel, Andreas ;

Scheiflinger, Friedrich ;

Reipert, Birgit M. ;

de la Rosa, Maurus .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (05) :1075-1080

[10] Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure [J].

Halbert, CL ;

Standaert, TA ;

Wilson, CB ;

Miller, AD .

JOURNAL OF VIROLOGY, 1998, 72 (12) :9795-9805

← 1 2 3 4 →